ISSX Conference 2023 | Boston, MA
Boston, MA, USA | 10 September 2023 - 13 September 2023
Overview
About Iain Shaw: Senior Director, 14C Enabled Drug Development
Iain Shaw is Senior Director of 14C Enabled Drug Development at Quotient Sciences. Iain has over 30 years of experience in the pharmaceutical industry, including more than 20 years of drug development experience.
Scientific Poster Spotlight: Understanding the Absorption, Metabolism, and Excretion of Masitinib in Healthy Male Subjects
At the International Society for the Study of Xenobiotics (ISSX) conference in September 2022, Quotient Sciences, AB Science, the Netherlands Organisation for Applied Scientific Research (TNO), and Pharmaron presented a poster investigating the absorption, metabolism, and excretion (ADME) of masitinib, an oral tyrosine-kinase inhibitor that targets mast cells and macrophages and is currently in development as a potential treatment for neurology, inflammatory diseases, oncology, and viral diseases.
Register
Location
Random Hotel
Boston, MA, USA